OptiPhos® Plus Receives Positive Opinion From EFSA

reading time
Product | 15.10.2020

Our next-generation phytase product, OptiPhos® Plus has received a positive opinion from the European Food Safety Authority (EFSA)

Positive opinions have been published by EFSA on the submitted registration file of OptiPhos® Plus, the latest intrinsic heat stable phytase. The reports state that OptiPhos® Plus already shows a significant improvement on phosphorus (P) digestion for all species at 250 FTU/kg. 

The fast approval of this dossier (within one year after its filing) proves that OptiPhos® Plus has passed the rigid and severe checks by EFSA on safety and efficacy without major remarks or discussions.

global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us


Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .




North America


South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.


United States

Click here to visit the local website or close this popup to stay on the global website.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now